China Grand Pharmaceutical and Healthcare Holdings logo

China Grand Pharmaceutical and Healthcare Holdings

Asia, Hong Kong Island, Hong Kong, Central

Description

China Grand Pharmaceutical and Healthcare Holdings engages in the development, manufacture and distribution of pharmaceutical products.

Investor Profile

China Grand Pharmaceutical and Healthcare Holdings has made 4 investments, with 0 in the past 12 months and 25% as lead.

Stage Focus

  • Series D (50%)
  • Series B (25%)
  • Series C (25%)

Country Focus

  • The Netherlands (50%)
  • Belgium (25%)
  • Italy (25%)

Industry Focus

  • Medical Device
  • Health Care
  • Therapeutics
  • Biotechnology
  • Manufacturing
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does China Grand Pharmaceutical and Healthcare Holdings frequently co-invest with?

DaVita Venture Group
North America, Colorado, United States, Denver
Co-Investments: 2
Boehringer Ingelheim Venture Fund
Europe, Rheinland-Pfalz, Germany, Ingelheim Am Rhein
Co-Investments: 1
Invest-NL
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 1
VI Partners
Europe, Schwyz, Switzerland, Altendorf
Co-Investments: 1
Ysios Capital
Europe, Pais Vasco, Spain, San Sebastian
Co-Investments: 1
Fund+
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 1
Kurma Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 1
European Innovation Council
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 1
EQT Life Sciences
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 2
BNP Paribas Private Equity
Europe, Ile-de-France, France, Paris
Co-Investments: 1

What are some of recent deals done by China Grand Pharmaceutical and Healthcare Holdings?

Xeltis

Eindhoven, Noord-Brabant, The Netherlands

Xeltis is a clinical-stage medtech company with the world’s most advanced polymer-based platform of restorative cardiovascular devices.

Health CareMedical DeviceTherapeutics
Series DAug 14, 2023
Amount Raised: $13,634,767
Xeltis

Eindhoven, Noord-Brabant, The Netherlands

Xeltis is a clinical-stage medtech company with the world’s most advanced polymer-based platform of restorative cardiovascular devices.

Health CareMedical DeviceTherapeutics
Series DFeb 21, 2023
Amount Raised: $34,084,542
InnovHeart

Milano, Lombardia, Italy

InnovHeart is a developer of transcatheter mitral valve replacement systems to treat patients suffering from mitral valve disease.

ManufacturingMedicalMedical Device
Series CJan 27, 2022
Amount Raised: $55,000,000
etherna immunotherapies

Niel, Antwerpen, Belgium

etherna develops mRNA and lipid nanoparticle solutions.

BiotechnologyHealth CareMedical DeviceTherapeutics
Series BJun 16, 2020
Amount Raised: $38,306,104